Prior administration of suxamethonium in patients intensifies the blocking effect of a subsequent dose of a non-depolarizing blocking drug, such as pancuronium [1, 2], vecuronium [2] [3] [4] [5] or atracurium [6, 7] . In contrast, suxamethonium injected during the course of a non-depolarizing block, at least in animals [8] , produces an obvious antagonism of the block. The latter is the expected interaction between two drugs with opposite mechanisms of action-postjunctional depolarization or agonist type activity with suxamethonium, and receptor antagonism with the non-depolarizing blocking drug. However, this may not be the entire explanation, because Kimura and colleagues [9] have shown that suxamethonium increases the evoked release of acetylcholine from the phrenic nerve terminals of the mouse. Such an effect would certainly contribute to antagonism of nondepolarizing block. In addition, the same authors [9] have shown that larger concentrations of suxamethonium exert the opposite effect on acetylcholine release, decreasing it substantially. If such a depressant effect on transmitter release is a delayed effect of normal doses, this could contribute to, or account for, potentiation of subsequent non-depolarizing blocking drugs. Other nicotinic agonists (nicotine, decamethonium, dimethylphenylpiperazinium and acetylcholine itself) have also been reported both to facilitate and to inhibit neurotransmitter release, the latter effect being both concentration-and time-dependent [10] [11] [12] .
Interactions between suxamethonium and non-depolarizing neuromuscular blocking drugs Prior administration of suxamethonium in patients intensifies the blocking effect of a subsequent dose of a non-depolarizing blocking drug, such as pancuronium [1, 2] , vecuronium [2] [3] [4] [5] or atracurium [6, 7] . In contrast, suxamethonium injected during the course of a non-depolarizing block, at least in animals [8] , produces an obvious antagonism of the block. The latter is the expected interaction between two drugs with opposite mechanisms of action-postjunctional depolarization or agonist type activity with suxamethonium, and receptor antagonism with the non-depolarizing blocking drug. However, this may not be the entire explanation, because Kimura and colleagues [9] have shown that suxamethonium increases the evoked release of acetylcholine from the phrenic nerve terminals of the mouse. Such an effect would certainly contribute to antagonism of nondepolarizing block. In addition, the same authors [9] have shown that larger concentrations of suxamethonium exert the opposite effect on acetylcholine release, decreasing it substantially. If such a depressant effect on transmitter release is a delayed effect of normal doses, this could contribute to, or account for, potentiation of subsequent non-depolarizing blocking drugs. Other nicotinic agonists (nicotine, decamethonium, dimethylphenylpiperazinium and acetylcholine itself) have also been reported both to facilitate and to inhibit neurotransmitter release, the latter effect being both concentration-and time-dependent [10] [11] [12] .
A possible mechanism through which drugs might produce changes in evoked transmitter release is by modifying the ionic currents at the motor nerve endings. It has been possible for some time to measure such currents [13] , but a problem has been that the methods used formerly to immobilize the muscle to prevent electrode breakage (tubocurarine block, excess Mg 2+ , lack of Ca 2+ ) themselves interfere with either nerve terminal ionic currents or the ability of drugs to modify these currents. More recently, an alternative method has become available. This makes use of a toxin, u-conotoxin, from the cone snail Conus geographus which, in low concentrations, selectively blocks sodium channels in muscle fibre membranes without affecting those in nerve [4, 15] . u-Conotoxin can therefore be used to abolish the muscle action potential and thereby prevent muscle contraction, without interfering with the generation of the nerve action potential. We have used u-conotoxin in some of the experiments described here, to paralyse isolated nerve-muscle preparations of the mouse triangularis sterni, in order to detect any effect of suxamethonium on currents in the nerve endings.
The perineural waveform we recorded comprises predominantly a double-peaked negative deflection, the first peak being associated with the inward movement of Na + ions at the nodes of Ranvier and at the heminode, and the second being associated mainly with the local circuit current that is generated by movement of K + outwards at the motor nerve terminals [13] . The outward K + current is analogous to the delayed rectifier current characteristic of the action potential in a non-myelinated nerve fibre. Its negative going peak masks underlying oscillations associated with Ca 2+ currents, which are exposed [16] [17] [18] [19] and probably enhanced [20] by 3,4-diaminopyridine (3,4-DAP), which blocks the main outward K + current. The exposed waves, in the presence of 3,4-DAP, correspond to an inward Ca 2+ current (I Ca ) and a delayed outward calcium-activated K + current (I KC a)j which is probably activated by the enhanced I Ca . We have confirmed and then utilized this action of 3,4-DAP in our studies of the effect of suxamethonium on neuronal electrophysiology.
Numerous experiments from this laboratory, and others, have shown that when the same dose of vecuronium is injected at intervals of 30 min or more, the second dose in the series produces a slightly greater block than the first, but the second and all subsequent injections produce virtually identical degrees of block [21] . This constancy of response to successive doses of vecuronium suggested that vecuronium was a useful drug to detect interactions with previously administered suxamethonium.
MATERIALS AND METHODS

Materials
u-Conotoxin GUI B was obtained from the Peptide Institute, Inc., Osaka, Japan. All other compounds were obtained from the Sigma Chemical Company, Poole, Dorset.
Tibialis anterior muscle of anaesthetized cats
Four cats (three male) were anaesthetized with a mixture of a-chloralose 80 mg kg" 1 and pentobarbitone 5 mg kg" 1 injected i.p. Lungs were ventilated with air at a rate of 26 b.p.m. at a tidal volume of approximately 13 ml kg" 1 , adjusted to maintain arterial pH at 7.3-7.4.
The right hind limb was immobilized and maximal twitches of the tibialis anterior muscle in response to single shock stimulation of the sciatic nerve were recorded using a Grass FTO3C force displacement transducer. The sciatic nerve was stimulated at a rate of 0.1 Hz using rectangular pulses of 0.1 ms duration and of a strength greater than that required to produce a maximal twitch. Drugs were injected i.v. through a cannula in the left femoral vein, or directly into the arterial supply to the tibialis anterior muscle by the method described by Brown [22] . Arterial pressure was recorded from a carotid artery using a Statham PC45 pressure transducer. Recordings were made on a Grass Model 5 ink oscillograph.
Potentiation. A series of three doses of vecuronium 40 ug kg" 1 was administered i.v. Sixty minutes after the second dose of the series, an i.v. dose of suxamethonium 100 ug kg" 1 was injected, followed by a second dose of suxamethonium 15 min later. The third dose of vecuronium was injected an additional 15 min later.
A control series of recordings was made in which only vecuronium was administered (two or more doses).
Antagonism. Tubocurarine 400 ug kg" 1 i.v. was administered. At the time of maximal block, suxamethonium 3 ug was injected i.a., followed by a second dose at approximately 40% recovery of block. The same procedure was repeated in the same cat on two or three occasions at intervals of 90 min.
Recordings were made from similar series in which vecuronium was used or suxamethonium 25 ug kg" 1 was injected i.v.
Mouse triangularis sterni preparations
Experiments were performed at room temperature (20-25 °C) . The left triangularis sterni nerve-muscle preparation [23] was isolated from 15-25 g male mice (Balb C strain). During dissection, the muscle with its three nerves was perfused continuously with a physiological salt solution of the following composition (mmol litre" 1 ): NaCl, 118.4; KC1, 4.7; MgSO 4 , 1.2; KH 2 PO 4 , 1.2; CaCl 2 , 2.5; NaHCO 3 , 25; glucose, 11.1. The solution was bubbled with oxygen containing 5 % carbon dioxide, which maintained a pH of 7.3.
The preparation was pinned thoracic side downwards to the base of a 3-ml tissue bath and perfused at a rate of 5-10 ml min" 1 with the physiological salt solution described above, to which tubocurarine 10 umol litre" 1 or u-conotoxin G III B 0.1 umol litre" 1 was added to prevent muscle twitching. In some experiments, the muscle fibres on both sides of the three nerves were cut as a further precaution against muscle twitching. The intercostal nerves were stimulated via a suction electrode every 2 s with pulses of 50 us duration and of a strength greater than that necessary to produce a maximal response. Drugs were added to the perfusion fluid. Presynaptic waveforms generated by nerve action potentials were recorded by a glass microelectrode (filled with sodium chloride 2 mol litre" 1 , resistance 5-15 Mft) placed inside the perineural sheath (near end-plate areas) of one of the branches of an intercostal nerve [16] [17] [18] . The potentials were recorded, amplified and stored as described previously [19] . We recorded and averaged 20-25 waveforms in each study. As the shape of the waveform recorded is dependent on the electrode position, waveforms were monitored continuously from the same site before and throughout application of drugs. Recording sites were rejected if the signal amplitude decreased by more than 10 % during the first 20 min before the addition of the compounds. Using this design, stable recordings could be obtained over a 180-min period in control solutions or in the presence of drugs.
The recording system had an overall passband of 10 kHz d.c. and signals were digitized at 25 kHz, which was more than twice the filter cut-off frequency (Nyquist criteria). The signals were analysed with a suite of purpose-designed programs [24] running on an IBM-compatible microcomputer (Vanilla, 286-12A).
A control series of presynaptic waveforms was recorded and averaged. Further series of recordings examined the effects of: 3,4-diaminopyridine (3,4-DAP) 400 umol litre" 1 alone; suxamethonium 1-100 umol litre" 1 alone; tetraethylammonium (TEA) 4 mmol litre" 1 in the presence of 3,4-DAP; suxamethonium 1-100 umol litre" 1 in the presence of 3,4-DAP 400 umol litre" 1 (both in preparations paralysed by tubocurarine 10 umol litre" 1 and in preparations to which TEA 4 mmol litre" 1 had been added); suxamethonium 0.5-300 umol litre" 1 in preparations paralysed by u-conotoxin 0.1 umol litre" 1 (and in which muscle fibres either were or were not cut). Figure 1 illustrates the interactions between suxamethonium and non-depolarizing blocking drugs on twitches evoked by nerve stimulation.
RESULTS
Tibialis anterior muscle of anaesthetized cats
After the application of suxamethonium 100 ug kg" 1 , the third dose of vecuronium 40 ug kg" 1 (the second of those illustrated) was potentiated compared with the second, the depth of block having increased from 68 % to 97 % ( fig. 1 A) . Similar effects were produced in each of the three cats in which this interaction was studied. Figure 1B illustrates the converse effect of suxamethonium: a maximal block produced by tubocurarine 400 (ig kg" 1 i.v. was antagonized by successive 3-ug doses of suxamethonium i.a. An antagonistic effect was also evident when suxamethonium 25 (ig kg" 1 was injected i.v. instead of i.a., but the abrupt effect on i.a. injection may be distinguished more easily on the spontaneous recovery curve. In addition, tubocurarine was chosen for this series of recordings because its spontaneous recovery curve is much slower than that of vecuronium, contributing further to a convincing demonstration of the antagonism by suxamethonium. (A similar effect is produced when vecuronium is infused in place of tubocurarine [25] .)
Mouse triangularis sterni perineural waveforms
The control series of perineural waveforms illustrated the predominant double-peaked negative deflections, in which the first negative deflection represents inward Na + currents at the nodes of Ranvier and heminodes, and the second deflection represents outward K + currents at the nerve terminals [13] (fig. 2) . 3,4-DAP 400 umol litre" 1 blocked the second deflection, exposing previously masked Ca 2+ currents-an inward Ca 2+ current (I Ca ) followed by a delayed outward calcium-activated K + current (I KCa ) ( fig. 2) .
In the absence of 3,4-DAP, suxamethonium 1-100 umol litre" 1 had no obvious effect on the double-peaked negative waveform, whether it was recorded in the presence of tubocurarine or of uconotoxin ( fig. 3) , and whether or not the muscle fibres were cut. There was no evidence of repetitive firing in the nerve, such as is produced by suxamethonium, in the absence of tubocurarine, in the motor nerves of the cat [26] .
In the presence of 3,4-DAP, the exposed outward I KCm was blocked by TEA 4 mmol litre" 1 and this had the effect of greatly enhancing the amplitude and duration of the waveform corresponding to Ic. [13, 17, 18] (fig. 4) . Suxamethonium 1-100 umol litre" 1 had no effect on the waveforms corresponding to Ic and I KCa in the presence of 3,4-DAP 400 umol litre" 1 in three preparations paralysed by tubocurarine 10 umol litre" 1 . It was also without much effect on the enlarged waveform corresponding to I u in three preparations in which the I KCl had been blocked by TEA 4 mmol litre" 1 ( fig. 4 ). In the absence of tubocurarine and TEA, suxamethonium 0.5-300 umol litre" 1 consistently produced a concentration-dependent increase in the amplitude of the waveform corresponding to 1ŵ hen the preparation was paralysed with u-conotoxin (1 umol litre" 1 ), and this was so whether or not the muscle fibres were cut ( fig. 5A, B and fig. 6 ). In six preparations (three cut, three not cut) the mean increases in amplitude of the waveform corresponding to Ic in the presence of suxamethonium 1, 10, 30 and 100 umol litre" 1 were 0.17 (0.004) mV, 0.28 (0.01) mV, 0.42 (0.016) mV and 0.53 (0.023) mV, respectively, each value significantly different from all the others (P < 0.05). Under these conditions, suxamethonium also modified the waveform corresponding to I KC ., but here the change produced depended upon whether or not the muscle fibres had been cut.
In the absence of cutting, when only u-conotoxin was present to paralyse the preparation, a small concentration of suxamethonium (1 umol litre" 1 ) enhanced and prolonged the I KCa waveform ( fig. 5A, C) . As the concentration of suxamethonium was increased, the peak of the I KCa waveform became smaller again until it was less than the control, but its duration remained greater than control, even though diminishing with successive increments in concentration ( fig. 5 A, C) .
In the cut preparation treated with u-conotoxin, the effect of suxamethonium on the I KCa waveform was much less striking. There was no increase in its peak and no prolongation with any concentration of suxamethonium. Instead, suxamethonium produced a concentration-dependent depression of its amplitude and duration ( fig. 6 ).
DISCUSSION
The results in anaesthetized cats confirmed the dual actions of suxamethonium in relation to nondepolarizing blocking drugs-antagonism when injected during non-depolarizing block, but potentiation when injected before the myoneural blocker. Antagonism is explained readily on the basis of enhanced evoked release of acetylcholine [9] synergizing with the postjunctional depolarizing action of suxamethonium, the latter effect decreasing the threshold to the transmitter, so that the critical degree of endplate potential necessary to trigger the contractile mechanism was reached sooner, and in more muscle fibres.
Acetylcholine release at the nerve endings is dependent upon, and a function of, the entry of calcium ions through voltage-operated Ca 2+ channels that are opened by depolarization of the nerve terminals as they are invaded by the nerve impulse. The inward flowing Ca J+ current is detectable by the technique of recording perineural waveforms, used in the present experiments on a mouse muscle. The Ca 2+ that enters not only activates the acetylcholine release mechanism, but also acts to open a population of calcium-activated K + channels. Hence, there is a secondary efflux of K + ions (I K c«) which presumably accelerates the repolarization of the membrane and thereby closes the Ca !+ channels. It may be that the secondary I KCa acts as a braking current on Ca 2+ entry to prevent the toxic consequences of excess intraterminaJ Ca 2+ [18] . The extent of the unchecked 1,^ was indicated by the great enhancement of the corresponding waveform when I KCm was blocked by tetraethylammonium.
When muscle contraction was prevented by \i-conotoxin, suxamethonium produced an increase in I Ca at the nerve terminals. The effect was detectable with concentrations less than 1 ^mol litre" 1 and increased with increasing concentration. The effective concentrations of suxamethonium are therefore well within those achieved clinically after the usual intubating dose of about 1 mg kg" 1 . Such is the sensitivity of transmitter release to Ca 2+ influx, that the ability of suxamethonium to increase 1^ is well able to account for the enhanced release of acetylcholine in response to a nerve impulse. It should be noted that suxamethonium is, here, apparently enhancing the opening of what have been regarded as specifically voltage-operated channels. Furthermore, as suxamethonium is a nicotinic agonist, and its effect is blocked by tubocurarine, it seems that the site of action of suxamethonium is a prejunctional nicotinic receptor. The arrangement appears to be unusual, therefore, in that a prejunctional nicotinic receptor is in some way coupled to, and facilitates the opening of, a voltage-operated Ca 2+ channel. Interaction of nicotinic agonists with voltage-operated Ca 2+ channels at the motor nerve terminal has been proposed by others also [15, 27, 28] , although to explain different phenomena, and on the basis of less direct evidence than that reported here. Nicotinic receptors coupled to ion channels that are relatively selective for Ca 2+ are being identified increasingly in nervous tissue [29] .
When the muscle fibres were not cut, the waveform corresponding to the secondary I KCa also was substantially enhanced (at least in terms of the area under the curve if not in peak amplitude) by small concentrations of suxamethonium within the clinical range. Presumably, the greater influx of Ca 2+ switched on and prolonged the opening of more Ca 2+ -activated K + channels. However, as the concentration of suxamethonium was increased, the secondary effect became less, to the extent that in some preparations I KCm was reduced to less than the control. We have no certain explanation for this depressant effect of large concentrations of suxamethonium on I KCa . Possibly, the excessive postjunctional endplate depolarization caused sufficient release of K + into the junction to oppose K + efflux from the nerve terminals. When the muscle fibres were cut in addition to being treated with uconotoxin, suxamethonium still enhanced the initial ICJ waveform, but under these conditions it only depressed the amplitude of I KCtt . We are inclined to attribute the absence of potentiation of I KCa to the increased extracellular concentration of K + arising from the cut muscle fibres. However, in general we are less confident about interpreting effects on I KCa than on 1,^. The 1^ occurs before the postjunctional endplate response, and the waveform corresponding to Ic is therefore a true reflection of the nerve terminal current. In contrast, the postjunctional endplate potential occurs during the I K ca, and we cannot exclude the possibility that some of the apparent changes in the waveform corresponding to IRCBJ m me presence of large concentrations of suxamethonium, might be artefacts caused by a modified endplate potential.
When the I KCli was blocked by TEA, suxamethonium had very little effect on the already greatly enhanced initial Ca 2+ influx. There are two possible explanations for this absence of effect of suxamethonium. In the presence of TEA, IQ, may already be maximal and so cannot be further increased. Also, TEA, in addition to blocking calcium-activated K + channels, is a nicotinic receptor antagonist, being particularly effective against neuronal nicotinic receptors [30] . Hence, it may simply antagonize suxamethonium at the postulated nerve terminal nicotinic receptors. We are inclined to favour this latter view, because in preliminary experiments in which the I KCa was blocked by the scorpion toxin, charybdotoxin [18] , instead of by TEA, we found that suxamethonium enhanced I Cs . Charybdotoxin is devoid of nicotinic receptor blocking action.
The experiments threw no light on the ability of suxamethonium to potentiate a subsequently administered non-depolarizing blocking drug. Results in which acetylcholine output was assayed directly [9] showed that large concentrations of suxamethonium decreased release. However, in the present experiments, even with very large concentrations of suxamethonium (300 (imol litre"')> the 1^ waveform was enhanced; there was no change that could account obviously for a decrease in transmitter release. We must therefore conclude either that the mouse nerve-muscle preparation is unsuitable to demonstrate the effect, or that the effect is dependent upon a pre-or postjunctional mechanism that was not detectable under the recording conditions used. Alternatively, the interaction seen in the intact organism may have a pharmacokinetic origin.
Suxamethonium had no effect on the doublepeaked negative waveform corresponding to I Na and I K . This indicates that suxamethonium does not produce a generalized depolarization of the nerve terminal membranes, as it is unlikely that such an effect would have left the Na + and K + waveforms unchanged. It is perhaps surprising that there was no clear change in the amplitude of the K + waveform, as it may be assumed that there was an underlying enhancement of the masked l^. However, because there may also have been enhancement of the opposing I KCa , the gross overall effect on the K + waveform may have been negligible for this reason. There was no evidence of repetitive firing in the nerve such as is produced by suxamethonium in cats [20, 31] . Such repetitive firing is generally attributed to alocalized depolarization that serves as a generator potential near the first node of Ranvier. Enhancement and spread of this depolarization by greater dosage is thought then to block conduction and consequently reduce transmitter output [32] . It may be that the mouse triangularis sterni terminals lack the type of prejunctional receptors that give rise to a generator potential and to terminal depolarization, and so the secondary decrease in transmitter release, although occurring in the mouse diaphragm [9] , does not occur in the triangularis sterni.
The question arises if the suxamethonium-sensitive receptors coupled to Ca 2+ channels are the same ones as those postulated to function in the positive feedback mechanism that enhances mobilization and thereby maintains transmitter output during high frequencies of nerve impulses [33, 34] . Ca 2+ influx may be responsible, not only for immediate release of transmitter, but also, via the synapsin I mechanism [35] , for shifting reserve vesicles into the immediately available store. If the same prejunctional receptors are involved, they will be sensitive not only to stable nicotinic agonists, but also to acetylcholine, including the neurotransmitter itself. Experiments to test this possibility are in progress, although the existence of the neurotransmitter is so fleeting that it is not clear how it could modify the voltage operated Ca 2+ channels opened by the next nerve impulse.
